Accuracy of New John Cunningham Virus Antibody Assay in Natalizumab-Treated Patients With Multiple Sclerosis

被引：0
作者：
Gelissen, Liza M. Y. [1 ]
Wijburg, Martijn T. [1 ]
Strijbis, Eva M. M. [1 ]
van Oosten, Bob W. [1 ]
de Jong, Brigit A. [1 ]
Uitdehaag, Bernard M. J. [1 ]
Rispens, Theo [2 ,3 ]
Feltkamp, Mariet C. W. [2 ,4 ]
van Kempen, Zoe L. E. [1 ]
Killestein, Joep [1 ]
机构：
[1] Vrije Univ Amsterdam, Amsterdam Univ Med Ctr UMC Locat Boelelaan, MS Ctr Amsterdam, Neurol,Amsterdam Neurosci, Amsterdam, Netherlands
[2] Sanquin Blood Supply, Res & Lab Serv Dept, Amsterdam, Netherlands
[3] Univ Amsterdam, Dept Immunopathol, Sanquin Res & Landsteiner Lab, Amsterdam UMC, Amsterdam, Netherlands
[4] Leiden Univ, Dept Med Microbiol & Infect Prevent, Med Ctr, Leiden, Netherlands
来源：
JAMA NEUROLOGY | 2025年
关键词：
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RISK;
D O I：
10.1001/jamaneurol.2025.0337
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Low natalizumab trough concentrations are associated with reduced seroconversion of the John Cunningham virus in natalizumab-treated patients with multiple sclerosis
    Gelissen, Liza M. Y.
    Toorop, Alyssa A.
    Schipper, Pien M.
    Hoitsma, Elske
    Zeinstra, Esther M. P. E.
    van Rooij, Luuk C.
    van Munster, Caspar E. P.
    Vennegoor, Anke
    Mostert, Jop
    Wokke, Beatrijs
    Kalkers, Nynke F.
    Hoogervorst, Erwin L. J.
    van Eijk, Jeroen
    Roosendaal, Christiaan M.
    Kragt, Jolijn J.
    Eurelings, Marijke
    van Genugten, Jessie
    Nielsen, Jessica
    Sinnige, L. G. F.
    Kloosterziel, Mark E.
    Arnoldus, Edo P. J.
    Bouvy, Willem H.
    Strijbis, Eva M.
    van Oosten, Bob
    De Jong, Brigit A.
    Uitdehaag, Bernard M. J.
    Lissenberg-Witte, Birgit, I
    Loeff, Floris C.
    Rispens, Theo
    Killestein, Joep
    van Kempen, Zoe L. E.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2025,
  • [2] John Cunningham virus conversion in relation to natalizumab concentration in multiple sclerosis patients
    van Kempen, Z. L. E.
    Leurs, C. E.
    de Vries, A.
    Vennegoor, A.
    Rispens, T.
    Wattjes, M. P.
    Killestein, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 (09) : 1196 - 1199
  • [3] JC virus urinary excretion and seroprevalence in natalizumab-treated multiple sclerosis patients
    Delbue, Serena
    Elia, Francesca
    Carloni, Camilla
    Pecchenini, Valentina
    Franciotta, Diego
    Gastaldi, Matteo
    Colombo, Elena
    Signorini, Lucia
    Carluccio, Silvia
    Bellizzi, Anna
    Bergamaschi, Roberto
    Ferrante, Pasquale
    JOURNAL OF NEUROVIROLOGY, 2015, 21 (06) : 645 - 652
  • [4] Glioblastoma in natalizumab-treated multiple sclerosis patients
    Morales, Fabian Sierra
    Wright, Robert B.
    Novo, Jorge E.
    Arvanitis, Leonidas D.
    Stefoski, Dusan
    Koralnik, Igor J.
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2017, 4 (07): : 512 - 516
  • [5] JC virus antibody index in natalizumab-treated patients: correlations with John Cunningham virus DNA and C-reactive protein level
    Lanzillo, Roberta
    Liuzzi, Raffaele
    Vallefuoco, Luca
    Moccia, Marcello
    Amato, Luca
    Vacca, Giovanni
    Vacchiano, Veria
    Portella, Giuseppe
    Morra, Vincenzo Brescia
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2014, 10 : 807 - 814
  • [6] Monitoring the John Cunningham virus throughout natalizumab treatment in multiple sclerosis patients
    Dominguez-Mozo, M. I.
    Garcia-Montojo, M.
    Arias-Leal, A.
    Garcia-Martinez, A.
    Santiago, J. L.
    Casanova, I.
    Galan, V.
    Arroyo, R.
    Fernandez-Arquero, M.
    Alvarez-Lafuente, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 (01) : 182 - 189
  • [7] JC Viremia in Natalizumab-Treated Patients with Multiple Sclerosis
    Major, Eugene O.
    Frohman, Elliot
    Douek, Daniel
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (23) : 2240 - 2241
  • [8] Risk perception in natalizumab-treated multiple sclerosis patients and their neurologists
    Heesen, Christoph
    Kleiter, Ingo
    Nguyen, Franziska
    Schaeffler, Nina
    Kasper, Juergen
    Koepke, Sascha
    Gaissmaier, Wolfgang
    MULTIPLE SCLEROSIS JOURNAL, 2010, 16 (12) : 1507 - 1512
  • [9] JC virus detection and JC virus-specific immunity in natalizumab-treated Multiple Sclerosis patients
    Mancuso, Roberta
    Saresella, Marina
    Hernis, Ambra
    Marventano, Ivana
    Ricci, Cristian
    Agostini, Simone
    Rovaris, Marco
    Caputo, Domenico
    Clerici, Mario
    JOURNAL OF TRANSLATIONAL MEDICINE, 2012, 10
  • [10] Review on PML Risk Stratification in Natalizumab-Treated Multiple Sclerosis Patients
    Grigoriadis, Nikolaos C.
    NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2011, 48 : 61 - 63
12345